Baird Financial Group
PJP icon

Baird Financial Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Baird Financial Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,887
Closed -$226K – 1303
2015
Q2 		$226K Buy
+2,887
New +$225K ﹤0.01% 1192

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Baird Financial Group's PJP Position: Q3 2015 in Review

Baird Financial Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2015, closing a stake of 2,887 shares — an estimated $226K sold.

Baird Financial Group first reported a position in PJP in Q2 2015 and held it in 1 quarter. The position peaked at $226K in Q2 2015. 106 funds tracked by Wall St. Rank hold PJP as of Q3 2015.

  • Baird Financial Group reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
  • Baird Financial Group sold 2,887 Invesco Pharmaceuticals ETF shares in Q3 2015, an estimated $226K.
  • Baird Financial Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2015 and held it in 1 quarter.
  • Baird Financial Group's Invesco Pharmaceuticals ETF position peaked at $226K in Q2 2015.
  • 106 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2015.

Based on Baird Financial Group's 13F filing for Q3 2015, filed 12 Nov 2015.